semaglutide oral cardiovascular indication news 2025 SELECT: Semaglutide's Impact on CVD Events Emerges Quickly FDA approves Novo Nordisk's oral

doi: 10.1152/ajpgi.00318.2012 97 RyderRE

Morgan found that current users purchase on average 8% less food - including snacks, soft drinks and high-carb products - compared with non-users

Beyond tirzepatide and retatrutide, Eli Lilly is also investing in oral GLP-1 therapies ( orforglipron ), aiming to provide convenient, effective alternatives to injections

Medical experts make sure that all our articles are accurate

"It's the type of fiber that just passes right through you, without triggering the release of any hormones." This story was edited by Jane Greenhalgh

This brings us, you mentioned about the Parkinson's, and when I reviewed the three randomized Parkinson's trials, they're all small, but it appears to be the first disease modifying drug ever in Parkinson's